Home Study Programs

At the completion of this activity, pharmacists will be able to:

* Demonstrate the importance of co-dispensing naloxone for patients with chronic pain and substance use
disorders (SUD) in our current healthcare landscape.
* Examine legal considerations for co-dispensing and co-prescribing naloxone in New Jersey along with
national, state, and organizational recommendations.
* Implement a naloxone co-dispensing program across various settings when approved by administration.
* Interpret the strategies and barriers to implementing a successful naloxone co-dispensing program in your
practice.
* Use various processes for mitigating stigma reduction in naloxone co-dispensing initiatives.
* Identify the process

At the completion of this activity, pharmacists will be able to:

1. Explain the impact to the patient when barriers limit the affordability of insulin and other medications for
diabetes.
2. Identify types of out-of-pocket costs that patients will pay to prescription benefit managers or health plans.
3. Describe terms which reflect patients' behaviors when they face barriers that limit access to insulin and other
medications for diabetes
4. Explain different types of health policies aimed at improving access to medications.
5. Define the term "transparency" and explain how this is important to understand costs that factor into drug
affordability.
6. Identify and describe types of fees in the pharmacy supply chain that include pharmaceutical manufacturers,
prescription benefits managers, and pharmacies
7. Define the term "monetary claw back" and explain the flow of money in the pharmacy supply chain.
8. Identify legal strategies for policymakers or the government to increase patient access to medications,
especially in health crises situations.
9. List types of health policies that could increase access to medications for insured versus uninsured patients.
10. Compare state data versus national data examining consumer copay costs to identify which states have
higher prescription copay costs.

At the completion of this activity, pharmacy technician will be able to:

1. Identify examples of the term out-of-pocket costs
2. List risk factors associated with poor health outcomes in patients wit diabetes mellitus
3. Outline patient behaviors when they face barriers that limit access to insulin and other medications for
diabetes
4. List different types of health policies aimed at improving access to medications
5. Explain the role of the health plan in establishing policies for patients

At the completion of this activity, pharmacists will be able to:

Identify changes to the immunization schedule in both
pediatrics and adults for 2020-2021

Examine CDC surveillance data for the 2020-2021 influenza season

Distinguish between the monitoring parameters and adverse reactions associated with each vaccine

Explain factors influencing vaccine hesitance and strategies for promoting vaccine acceptance

Identify the various resources available to pharmacists for immunization information

At the completion of this activity, pharmacy technicians will be able to:

Distinguish pediatric vaccines versus adult vaccine
formulations

Identify new vaccine formulations available in the U.S.

Recognize where immunization recommendations can be found

List reasons for vaccine hesitancy among patients

Define appropriate storage requirements for vaccines

At the completion of this activity, pharmacists will be able to: Define the term of "batching" compounded sterile products (CSPs) Identify different factors that can alter the intended use of dispensed IV compounded sterile products (CSPs) Analyze changes to the batching process and its impact on pharmacy services

At the completion of this activity, pharmacists will be able to:

Describe the clinical presentation associated with Morgellons disease (MD)

Identify potential pharmacological treatment options for MD

At the completion of this activity, pharmacists will be able to:

Describe the results of a national survey of Americans’ perception of the impact of COVID-19 on the prescription drug supply Explain national survey results with regards to Americans’ perception of how the SARS-CoV-2 virus is transmitted. Discuss the likelihood of Americans to receive the coronavirus vaccine, receive COVID-19 testing at a pharmacy, and to be initiated on COVID-19 treatment by a pharmacist

At the completion of this activity, pharmacists will be able to:

Define the layered learning practice model Describe the benefits of utilizing the layered learning practice model

At the completion of this activity, pharmacists will be able to:

Distinguish differences in the terminology related to cannabis, including hemp, marijuana, cannabidiol, and tetrahydrocannabinol (THC) Recognize the pharmacology, potential medical uses, and adverse effects of cannabis and cannabinoids Identify United States (U.S.) Food and Drug Administration (FDA) approved products related to cannabis Explain the history of federal and state regulatory status of medical cannabis, including approved medical indications for use in New Jersey Describe the pharmacist’s role in educating patients on medical use of cannabis and cannabidiol (CBD)

Objectives

At the completion of this activity, pharmacists will be able to:

Identify complications of Behcet's disease  List challenges in providing nutrition to a patient with Behcet's disease Describe why parenteral nutrition may be indicated in patients with Behcet's disease